Health Care / Hospitals
Releases published in the last 30 days. 
Page 2 of 3
- Pilot Study Demonstrates Feasibility of Digital Tool for Dietary Goal Setting in Primary Care Diabetes Management
- 7/9/2025 2:16:55 PM
- A recent study in the Journal of Nutrition Education and Behavior, published by Elsevier, evaluated the feasibility of Nutri, a user-centered digital platform designed to support personalized, evidence-based diet goal setting during routine primary care visits for patients with type 2 diabetes.
- WHO, UNICEF update country tracker on water, sanitation and hygiene in health-care facilities, showing progress across 107 countries
- 7/9/2025 2:12:38 PM
- The World Health Organization (WHO) and UNICEF have released an updated country progress tracker that shows how countries are advancing efforts to improve water, sanitation, hygiene (WASH) and waste services in health-care facilities.
- How does body mass index affect breast cancer risk in postmenopausal women with and without cardiovascular disease?
- 7/8/2025 1:50:45 PM
- New research reveals that excess weight is linked to an especially high risk of developing breast cancer in postmenopausal women with cardiovascular disease.
- Imfinzi approved in the EU as first and only perioperative immunotherapy for muscle-invasive bladder cancer
- 7/8/2025 1:31:49 PM
- AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) for the treatment of adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as monotherapy adjuvant treatment after radical cystectomy (surgery to remove the bladder).
- Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo
- 7/8/2025 1:14:28 PM
- Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA approved to treat schizophrenia and is the first and only approved treatment for bipolar I and II depression as an adjunctive and monotherapy With the addition of CAPLYTA® to Johnson & Johnson’s robust …
- Prenuvo-Enabled Research Wins 2025 Journal of Alzheimer’s Disease Alzheimer Award
- 7/8/2025 11:46:59 AM
- Prenuvo, the leading whole-body MRI for proactive health screening, today announced research powered by its imaging dataset has received the prestigious 2025 Alzheimer Award from the Journal of Alzheimer’s Disease (JAD).
- Sirtex Medical’s SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
- 7/8/2025 10:57:40 AM
- Sirtex Medical (“Sirtex”), a leading manufacturer of interventional oncology solutions, announced that the U.S. Food and Drug Administration (FDA) approved SIR-Spheres® Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma (HCC) in the United States.
- Tietoevry Recognized in Gartner® Hype Cycle™ for Healthcare Providers, 2025 for Semantic Interoperability
- 7/8/2025 10:55:05 AM
- Tietoevry Care is proud to announce its inclusion in the Gartner® Hype Cycle™ for Healthcare Providers, 2025 as a sample vendor in semantic interoperability, a key enabler of integrated, data-driven healthcare across Europe. “We are proud to be acknowledged by Gartner for our work in advancing interoperability,” said Ari Järvelä, Managing Director at Tietoevry …
- New website on cholera control goes live
- 7/7/2025 10:40:17 AM
- The Global Task Force on Cholera Control (GTFCC), which brings together more than 50 nongovernmental organizations, academic institutions and UN agencies, and is hosted by the World Health Organization, has launched a new website.
- ConV2X Drops Draft Agenda for 2025 Decentralized Health & Life Sciences Event
- 7/7/2025 8:00:00 AM
- ConV2X, the premier conference for emerging and decentralized technologies in healthcare and life sciences, has officially released the draft agenda for its highly anticipated event, ConV2X 2025: Driving Platforms & Decentralized Tech in Healthcare and Life Sciences, to be held September 25–26, 2025, in Cambridge, Massachusetts.
- Sudan: Sharp Rise in Attacks on Healthcare After Two Years of Conflict with 1,000 People Killed this Year
- 7/4/2025 10:50:28 AM
- Nearly 1,000 people have been killed so far this year in Sudan while seeking health care or visiting loved ones in hospital, with attacks on hospitals nearly tripling after two years of conflict[1] and exacerbating a cholera outbreak, Save the Children said.
- AdvaMed Statement on the Tax Bill
- 7/4/2025 10:38:57 AM
- AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the impact the “One Big Beautiful Bill Act” will have on medtech innovation: “AdvaMed thanks President Trump, Vice President Vance, Senate Republican Leader Thune, House Speaker Mike Johnson, Senate Finance Chairman Crapo, and House Ways & Means Chairman Smith for the …
- AMA: Congress moves health care in wrong direction
- 7/4/2025 10:34:55 AM
- Statement attributable to: Bobby Mukkamala, M.D. President, American Medical Association “Today is a sad and unnecessarily harmful day for patients and health care across the country, and its impact will reverberate for years.
- Readout on WHO participation in global nuclear emergency exercise
- 7/3/2025 10:29:44 AM
- On 25 June, the World Health Organization (WHO) concluded its participation in a 36-hour nuclear emergency exercise organized by the International Atomic Energy Agency (IAEA).
- What Are They Vaping? Study Reveals Alarming Surge in Adolescent Vaping of THC, CBD, and Synthetic Cannabinoids
- 7/3/2025 9:44:22 AM
- Novel research has revealed that adolescent vaping of current delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and synthetic cannabinoids (SCs) has increased between 2021 and 2023.
- Hyundai and the Van Gogh Museum bring seniors and art together during Connection Day
- 7/3/2025 9:16:16 AM
- This special day is designed for seniors who face challenges in experiencing art independently, connecting them with the work and life of Vincent van Gogh.
- Infection Control Resources to Detect Klebsiella and Other Pathogens in Healthcare Environments
- 7/3/2025 12:09:14 AM
- Klebsiella is described by the Centers for Disease Control and Prevention (CDC) as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs).
- AMA statement on Senate passing reconciliation bill
- 7/2/2025 10:17:48 AM
- Statement attributable to: Bobby Mukkamala, M.D. President, American Medical Association “When the House passed its reconciliation bill, the AMA made clear that any legislation Congress passes must not result in millions of Medicaid patients losing access to coverage.
- The solution to one of the world’s most pressing health crises might be hiding in your toilet
- 7/2/2025 3:53:34 AM
- Scientists at the University of Southampton are enlisting the public to become citizen scientists in the fight against antibiotic resistance. At the Royal Society Summer Science Exhibition, which opens to the public in London, visitors will be invited to help find phages, tiny viruses that could be key to combating antimicrobial resistance (AMR).
- Mitigating Legionella Exposure Risks in Hot Tubs throughout Puerto Rico
- 6/30/2025 7:34:13 PM
- Legionella is a type of bacteria that is naturally found in water, especially warm water. It is also the cause of Legionnaires’ disease and Pontiac fever, which can occur when people inhale small water droplets containing it.
- « Previous
- 1
- 2
- 3
- Next »